Abcam Plc (ABC) Earns “Add” Rating from Numis Securities Ltd
Numis Securities Ltd reissued their add rating on shares of Abcam Plc (LON:ABC) in a research report released on Thursday. Numis Securities Ltd currently has a GBX 1,116 ($14.54) target price on the stock.
Several other equities research analysts have also weighed in on the company. Berenberg Bank assumed coverage on Abcam Plc in a research report on Tuesday, June 27th. They issued a buy rating and a GBX 1,100 ($14.33) target price on the stock. Stifel Nicolaus reaffirmed a hold rating and issued a GBX 890 ($11.59) target price on shares of Abcam Plc in a research report on Tuesday, April 4th. Finally, Panmure Gordon reaffirmed a sell rating and issued a GBX 680 ($8.86) target price on shares of Abcam Plc in a research report on Thursday, April 20th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. Abcam Plc currently has a consensus rating of Hold and a consensus target price of GBX 900 ($11.72).
Abcam Plc (LON ABC) opened at 1019.00 on Thursday. The stock’s market capitalization is GBX 2.06 billion. The company has a 50-day moving average of GBX 977.98 and a 200-day moving average of GBX 900.27. Abcam Plc has a 52-week low of GBX 714.00 and a 52-week high of GBX 1,033.00.
In related news, insider Mara G. Aspinall bought 2,700 shares of the company’s stock in a transaction on Monday, June 5th. The shares were purchased at an average cost of GBX 979 ($12.75) per share, with a total value of £26,433 ($34,435.90).
Abcam Plc Company Profile
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.